Terms: = Prostate cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Diagnosis
10 results:
1. Detection of Individual prostate cancer Foci via Multiparametric Magnetic Resonance Imaging.
Johnson DC; Raman SS; Mirak SA; Kwan L; Bajgiran AM; Hsu W; Maehara CK; Ahuja P; Faiena I; Pooli A; Salmasi A; Sisk A; Felker ER; Lu DSK; Reiter RE
Eur Urol; 2019 May; 75(5):712-720. PubMed ID: 30509763
[TBL] [Abstract] [Full Text] [Related]
2. The
Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
[TBL] [Abstract] [Full Text] [Related]
3. Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy.
Han JS; Toll AD; Amin A; Carter HB; Landis P; Lee S; Epstein JI
Urology; 2012 Oct; 80(4):883-8. PubMed ID: 22921697
[TBL] [Abstract] [Full Text] [Related]
4. Histopathology of localized prostate cancer. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
[TBL] [Abstract] [Full Text] [Related]
5. Cytogenetics of prostate cancer. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Debruyne FM; Collins VP; van Dekken H; Jenkins RB; Klocker H; Schalken JA; Sesterhenn IA
Scand J Urol Nephrol Suppl; 1994; 162():65-71; discussion 115-27. PubMed ID: 7817161
[TBL] [Abstract] [Full Text] [Related]
6. Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Andersson L; Hagmar B; Ljung BM; Skoog L
Scand J Urol Nephrol Suppl; 1994; 162():43-9; discussion 115-27. PubMed ID: 7817160
[TBL] [Abstract] [Full Text] [Related]
7. Imaging in the diagnosis and assessment of prognosis in localized prostate cancer. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Høisaeter PA; Norlén BJ; Norming U; Ebert T; Mattrey R; Nilsson S; Norberg M; Pollack H; Salo J; Torp-Pedersen S
Scand J Urol Nephrol Suppl; 1994; 162():89-106; discussion 115-27. PubMed ID: 7529431
[TBL] [Abstract] [Full Text] [Related]
8. Tumor markers. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
[TBL] [Abstract] [Full Text] [Related]
9. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A
Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429
[TBL] [Abstract] [Full Text] [Related]
10. The TNM system of 1992. Comments from the TNM working group. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Chisholm GD; Hedlund PO; Adolfsson J; Denis LJ; Friberg S; Johansson JE; Peeling B
Scand J Urol Nephrol Suppl; 1994; 162():107-14; discussion 115-27. PubMed ID: 7529428
[TBL] [Abstract] [Full Text] [Related]
